Presenting the first edition of our Integrated Report
Human Technopole aims to develop a centre of excellence for life sciences in Italy, establishing a relationship with the external community on the basis of the values and principles of innovation and cultural openness.
In line with this role, Human Technopole has decided to publish, on a voluntary basis, it’s first Integrated Report referring to the year 2020.
The Integrated Report is the reporting tool through which Human Technopole will communicate to all stakeholders its commitment to social responsibility, based on transparency and accurate and complete information, in the hope that this can promote trust towards the work carried out by HT and the goals it has achieved.
The content of the Integrated Report highlights the links between strategy, Governance, value creation model, overall performance and future developments of Human Technopole. In addition and over time, the Integrated Report will also transparently document progress in the implementation of the UN 2030 Agenda and its Sustainable Development Goals, ensuring a constant and open dialogue with all stakeholders.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.